Proteome Sciences (LON:PRM) Trading Down 13.6% – Here’s Why

Shares of Proteome Sciences plc (LON:PRM) traded down 13.6% during trading on Tuesday . The company traded as low as GBX 2.51 ($0.03) and last traded at GBX 2.51 ($0.03). 100,008 shares traded hands during mid-day trading, a decline of 56% from the average session volume of 229,221 shares. The stock had previously closed at GBX 2.90 ($0.04).

Proteome Sciences Trading Up 3.2 %

The company has a market capitalization of £8.83 million, a price-to-earnings ratio of -2.17 and a beta of 0.07. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66. The business’s 50 day moving average price is GBX 3.86 and its two-hundred day moving average price is GBX 3.46.

Proteome Sciences (LON:PRM) last posted its earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) earnings per share for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.